Preparation and Characterization of Controlled-Release Floating Bilayer Tablets of Esomeprazole and Clarithromycin
暂无分享,去创建一个
A. di Cerbo | M. Israr | Abdulhakeem S. Alamri | M. Muzammal | S. Ghazanfar | Ashfaq Ahmad | N. Pugliese | A. Farid | K. Khan | Syed Mohammed Basheeruddin Asdaq
[1] T. Sandhya. Formulation and Evaluation of Sustained Release Bilayer Tablets of Losartan Potassium , 2021, ASIAN JOURNAL OF PHARMACEUTICS.
[2] Murad Alam,et al. Formulation and in vitro Evaluation of Effervescent Bilayer Floating Controlled Release Tablets of Clarithromycin and Famotidine , 2021, Research Journal of Pharmacy and Technology.
[3] C. Kao,et al. To control floating drug delivery system in a simulated gastric environment by adjusting the Shell layer formulation , 2021, Biomaterials Research.
[4] Sumeet Gupta,et al. Clarithromycin Solid Lipid Nanoparticles for Topical Ocular Therapy: Optimization, Evaluation, and In Vivo Studies , 2021, Pharmaceutics.
[5] H. Khan,et al. Design, Preparation and evaluation of various parameters of controlled release matrices of losartan potassium using polymers combination. , 2020, Pakistan journal of pharmaceutical sciences.
[6] Ira,et al. Floating Drug Delivery Systems: A Review , 2010 .
[7] N. Damodharan,et al. Floating Drug Delivery an Emerging Technology with Promising Market value , 2020 .
[8] T. Pavani,et al. Formulation development and in-vitro evaluation of Molsidomine matrix tablets for colon specific release , 2020 .
[9] Dharmendra Jain,et al. Floating Drug Delivery Systems: An Emerging Trend for the Treatment of Peptic Ulcer. , 2019, Current drug delivery.
[10] Wei He,et al. Design and optimization of gastro‐floating sustained‐release tablet of pregabalin: In vitro and in vivo evaluation , 2018, International journal of pharmaceutics.
[11] S. Puttipipatkhachorn,et al. Development of curcumin floating tablets based on low density foam powder , 2016 .
[12] H. Khan,et al. Formulation and in-vitro evaluation of directly compressed controlled release matrices of Losartan Potassium using Ethocel Grade 100 as rate retarding agent. , 2015, International journal of pharmaceutics.
[13] Xiaole Qi,et al. Floating tablets for controlled release of ofloxacin via compression coating of hydroxypropyl cellulose combined with effervescent agent. , 2015, International journal of pharmaceutics.
[14] R. Gupta,et al. Formulation and evaluation of novel stomach specific floating microspheres bearing famotidine for treatment of gastric ulcer and their radiographic study , 2014 .
[15] Harshal Ashok Pawar,et al. Development and evaluation of gastroretentive floating tablets of an antidepressant drug by thermoplastic granulation technique , 2014 .
[16] A. El-Kamel,et al. Design and evaluation of gastroretentive levofloxacin floating mini-tablets-in-capsule system for eradication of Helicobacter pylori , 2014, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.
[17] M. Hussain,et al. FORMULATION AND EVALUATION OF SUSTAINED RELEASE BILAYERED MATRIX TABLETS OF SILDENAFIL CITRATE , 2014 .
[18] K. Shah,et al. Formulation and Evaluation of Tramadol HCl Matrix Tablets Using Carbopol 974P and 934 as Rate-Controlling Agents , 2013 .
[19] J. Fitzpatrick. Powder properties in food production systems. , 2013 .
[20] Min Zhang,et al. Handbook of food powders: processes and properties , 2013 .
[21] S. Saisivam,et al. Development of Floating Matrix Tablets of Losartan Potassium: In Vitro and in Vivo Evaluation , 2013 .
[22] A. Qaddumi,et al. Weight and content uniformity of lorazepam half-tablets: A study of correlation of a low drug content product. , 2013, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.
[23] B. Nanjwade,et al. Development and evaluation of glipizide floating tablet , 2012 .
[24] G. Rathnam,et al. FORMULATION AND CHARACTERIZATIOIN OF BILAYER FLOATING TABLETS OF RANITIDINE , 2010 .
[25] P. Malfertheiner,et al. Helicobacter pylori infection: a clinical overview. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[26] Muralidhar Nama,et al. Formulation and Evaluation of Gastroretentive Dosage Forms of Clarithromycin , 2008, AAPS PharmSciTech.
[27] Javed Ali,et al. Floating drug delivery systems: A review , 2005, AAPS PharmSciTech.
[28] Y. Chien,et al. Statistical optimization of gastric floating system for oral controlled delivery of calcium , 2001, AAPS PharmSciTech.
[29] C. O'Morain,et al. Treatment of Helicobacter pylori , 2005, Helicobacter.
[30] Thomas J. Johnson,et al. Esomeprazole: a clinical review. , 2002, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[31] P. Costa,et al. Modeling and comparison of dissolution profiles. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[32] Thomas K. Hunt,et al. ON THE TREATMENT OF , 1846 .